ROIV Competitors & Alternatives
Compare Roivant Sciences Ltd with similar stocks in the same industry
Biotechnology
ROIV
Main Stock$31.98
Tradestie Score
63
Market Cap
$10.76B
Revenue Growth
-0.7%
Analyst Upside
+22.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$101.30
|
$31.13B | - | 61 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.88
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$25.93
|
$19.56B | 19.3 | 62 | Compare |
|
INCY
Incyte Genomics Inc
|
$104.55
|
$16.93B | 13.9 | 60 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$54.92
|
$15.70B | 27.9 | 60 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.29
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$237.15
|
$12.36B | 26.4 | 55 | Compare |
|
EXEL
Exelixis Inc
|
$51.50
|
$11.09B | 17.2 | 60 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$61.41
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.95
|
$10.53B | 39.3 | 65 | Compare |
More ROIV Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry